Identified as working in the space of Broad Spectrum Anti-Virals, Lab11 Therapeutics LLC is identified as a startup biotech company using human genetics as a lead towards therapy development using the latest in technology to design, test, validate and improve drugs. Developing drugs that would allow to be prepared for novel viral pandemics, with a strong J&J association in New York and Washington DC, the firm is working on two programs developing host-mediated broad spectrum antivirals: 1) small-molecule broad spectrum, and 2) mRNA mediated delivery of host antiviral effectors, serving as broad spectrum antivirals. Broad spectrum antivirals do not exist.
